Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice.
暂无分享,去创建一个
M. Capecchi | E. Ezan | P. Corvol | D. Ertoy | K. Bernstein | R. Sutliff | H. Lin | T. Guyene | J. Cole | T. Guyene | Justin Cole | Hsinchen Lin
[1] A. Disney,et al. The effect of angiotensin II receptor antagonist on the exogenous erythropoietin requirement of haemodialysis patients. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] I. Macdougall. The role of ACE inhibitors and angiotensin II receptor blockers in the response to epoetin. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[3] I. Wilson,et al. Erythropoietin receptor activation by a ligand-induced conformation change. , 1999, Science.
[4] I. Dimopoulou,et al. Association between activation of the renin-angiotensin system and secondary erythrocytosis in patients with chronic obstructive pulmonary disease. , 1999, The American journal of medicine.
[5] A. Goldfarb-Rumyantzev,et al. Effect of Angiotensin-Converting Enzyme Inhibitors on Response to Erythropoietin Therapy in Chronic Dialysis Patients , 1998, American Journal of Nephrology.
[6] B. Bourgeon,et al. High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[7] A. Cumano,et al. Jak2 Deficiency Defines an EssentialDevelopmental Checkpoint in DefinitiveHematopoiesis , 1998, Cell.
[8] J. Marine,et al. Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors , 1998, Cell.
[9] B. Julian,et al. Angiotensin II stimulates proliferation of normal early erythroid progenitors. , 1997, The Journal of clinical investigation.
[10] M. Capecchi,et al. The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. , 1997, The Journal of clinical investigation.
[11] M. Perazella,et al. Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: any evidence of erythropoietin resistance? , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[12] E. Scheuermann,et al. Mechanism of angiotensin converting enzyme inhibitor-related anemia in renal transplant recipients. , 1996, Kidney international.
[13] B. Suh,et al. Effect of captopril in the treatment of erythrocytosis after renal transplantation. , 1996, Transplantation proceedings.
[14] M. Capecchi,et al. Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[15] S. E. Brodie. New York, New York, USA , 1996 .
[16] J. Ménard,et al. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. , 1996, The Journal of clinical investigation.
[17] A. Kliger,et al. Enalapril treatment of posttransplant erythrocytosis: efficacy independent of circulating erythropoietin levels. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[18] J. Ménard,et al. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. , 1995, Circulation.
[19] B. Berk,et al. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor , 1995, Nature.
[20] J. Hodgin,et al. A noninvasive computerized tail-cuff system for measuring blood pressure in mice. , 1995, Hypertension.
[21] P Corvol,et al. Peptidyl dipeptidase A: angiotensin I-converting enzyme. , 1995, Methods in enzymology.
[22] G. J. Bhat,et al. Angiotensin II stimulates sis-inducing factor-like DNA binding activity. Evidence that the AT1A receptor activates transcription factor-Stat91 and/or a related protein. , 1994, The Journal of biological chemistry.
[23] B. Julian,et al. Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis. , 1994, Kidney international.
[24] D. Bonnet,et al. Direct and reversible inhibitory effect of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (Seraspenide) on the growth of human CD34+ subpopulations in response to growth factors. , 1993, Blood.
[25] P. Conlon,et al. The beneficial effect of enalapril on erythrocytosis after renal transplantation. , 1993, Transplantation.
[26] H. Eiskjær,et al. Elevated level of erythropoietin in congestive heart failure Relationship to renal perfusion and plasma renin , 1993, Journal of internal medicine.
[27] A. Riches,et al. The mechanism of action of the tetrapeptide Acetyl‐N‐Ser‐Asp‐Lys‐Pro (AcSDKP) in the control of haematopoietic stem cell proliferation , 1992, Cell proliferation.
[28] B. Julian,et al. Effects of enalapril on erythrocytosis after renal transplantation. , 1991, Annals of internal medicine.
[29] C. Créminon,et al. Negative regulator of pluripotent hematopoietic stem cell proliferation in human white blood cells and plasma as analysed by enzyme immunoassay. , 1990, Biochemical and biophysical research communications.
[30] O. Nielsen,et al. Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy. , 1990, Scandinavian journal of clinical and laboratory investigation.
[31] I. Seferyńska,et al. Erythropoietin production in exhypoxic polycythemic mice. , 1989, The American journal of physiology.
[32] E. Guittet,et al. Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[33] J. A. Micales,et al. PHYSIOLOGICAL CHARACTERISTICS OF A , 1989 .
[34] R. van Furth,et al. Determination of blood volume in the mouse with 51chromium-labelled erythrocytes. , 1984, Journal of immunological methods.
[35] J. Melby,et al. ENALAPRIL (MK-421) AND THE WHITE CELL COUNT AND HAEMATOCRIT , 1982, The Lancet.
[36] E. L. Green. Biology of the laboratory mouse , 1966 .